Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn


Coronavirus: A guide for Aussie investors

Emma Rapaport  |  17 Mar 2020Text size  Decrease  Increase  |  
Email to Friend

Below is our latest coverage of the coronavirus sell-off including daily market updates and commentary from head of equity research Peter Warnes.

It's natural to worry about the impact of coronavirus on your investments. As Morningstar’s head of behavioural sciences Steve Wendel puts it, panic is a social phenomenon, whether it’s panicked selling of investments or panicked buying of toilet paper.

To be sure, expect volatility in the short run. The economic hit to 2020 will be significant, and prolonged disruption will have an impact on the cash flows of many companies. 

But Morningstar analysts believe the collective global effort to lead to containment of the outbreak sometime over the next nine months.

"We expect near-term impact to be savage, shaving off 2 percentage points from global GDP growth," Morningstar director of equity research Johannes Faul says in a special report on the coronavirus.

"However, we anticipate a vaccine ready to be deployed by mid- to late 2021, setting the stage for a return to normality."

During periods of market volatility or where prices fall, it's often a time where you should consider adding more to your investments rather than taking them away. Warren Buffett always says that he likes his stocks the way he likes his socks: on sale.

Investing Compass
Listen to Morningstar Australia's Investing Compass podcast
Take a deep dive into investing concepts, with practical explanations to help you invest confidently.
Investing Compass

To make sure you’re headed in the right direction, we're curated a list of our latest coronavirus coverage. 

Latest updates:

5 new quality cheap stocks for your watchlist27 March

Investing basics: understanding ETF discounts and premiums during turbulent times27 March

Prem Icon The virus will run its course but the pain of record debt will become more acute26 March

[Video] How to avoid dividend cuts27 March

Coronavirus special report

Prem Icon Coronavirus: Market Temperature Check | Full report

For access to a list of 40 best ideas named in the report subscribe to Morningstar Premium or take a free trial.

Our perspective on the markets

Peter Warnes commentary (Premium)

Investment opportunities

Prem Icon Latest updates: Morningstar 5-star stock screener

How to protect your financial well-being

Coronavirus impact on industries, companies and financial products

As it happens | daily market updates

  • Daily updates for Morningstar Premium subscribers - click here
  • If you're not a Premium subscriber - click here

A letter from Morningstar Inc.'s CEO - 19 March

We are evaluating our coverage for you during these times of uncertainty. If you have questions or comments, we'd love to hear from you at mark.lamonica1@morningstar.com.

is the editorial manager for Morningstar Australia. Connect with Emma on Twitter @rap_reports. You can email Morningstar's editorial team editorialAU[at]morningstar[dot]com

© 2022 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written consent of Morningstar. Any general advice or 'regulated financial advice' under New Zealand law has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. For more information, refer to our Financial Services Guide (AU) and Financial Advice Provider Disclosure Statement (NZ). Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Morningstar’s full research reports are the source of any Morningstar Ratings and are available from Morningstar or your adviser. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782. The article is current as at date of publication.

Email To Friend